These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26694971)

  • 1. Receptor editing and genetic variability in human autoreactive B cells.
    Lang J; Ota T; Kelly M; Strauch P; Freed BM; Torres RM; Nemazee D; Pelanda R
    J Exp Med; 2016 Jan; 213(1):93-108. PubMed ID: 26694971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
    Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
    J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
    Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
    J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells.
    Lang J; Arnold B; Hammerling G; Harris AW; Korsmeyer S; Russell D; Strasser A; Nemazee D
    J Exp Med; 1997 Nov; 186(9):1513-22. PubMed ID: 9348309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VprBP Is Required for Efficient Editing and Selection of Igκ+ B Cells, but Is Dispensable for Igλ+ and Marginal Zone B Cell Maturation and Selection.
    Palmer VL; Aziz-Seible R; Kassmeier MD; Rothermund M; Perry GA; Swanson PC
    J Immunol; 2015 Aug; 195(4):1524-37. PubMed ID: 26150531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ig light chain receptor editing in anergic B cells.
    Tze LE; Baness EA; Hippen KL; Behrens TW
    J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen.
    Lang J; Jackson M; Teyton L; Brunmark A; Kane K; Nemazee D
    J Exp Med; 1996 Nov; 184(5):1685-97. PubMed ID: 8920858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification.
    Pelanda R; Schwers S; Sonoda E; Torres RM; Nemazee D; Rajewsky K
    Immunity; 1997 Dec; 7(6):765-75. PubMed ID: 9430222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory.
    Koenig-Marrony S; Soulas P; Julien S; Knapp AM; Garaud JC; Martin T; Pasquali JL
    J Immunol; 2001 Feb; 166(3):1463-70. PubMed ID: 11160185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens.
    Halverson R; Torres RM; Pelanda R
    Nat Immunol; 2004 Jun; 5(6):645-50. PubMed ID: 15156139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.
    Akerlund J; Getahun A; Cambier JC
    J Autoimmun; 2015 Aug; 62():45-54. PubMed ID: 26152931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.
    Prak EL; Trounstine M; Huszar D; Weigert M
    J Exp Med; 1994 Nov; 180(5):1805-15. PubMed ID: 7964462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired receptor editing in the primary B cell repertoire of BASH-deficient mice.
    Hayashi K; Nojima T; Goitsuka R; Kitamura D
    J Immunol; 2004 Nov; 173(10):5980-8. PubMed ID: 15528332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
    Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
    J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor editing: an approach by autoreactive B cells to escape tolerance. The Journal of Experimental Medicine. 1993. 177: 999-1008.
    Gay D; Saunders T; Camper S; Weigert M
    J Immunol; 2011 Feb; 186(3):1303-12. PubMed ID: 21248268
    [No Abstract]   [Full Text] [Related]  

  • 20. An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system.
    Ait-Azzouzene D; Verkoczy L; Peters J; Gavin A; Skog P; Vela JL; Nemazee D
    J Exp Med; 2005 Mar; 201(5):817-28. PubMed ID: 15738053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.